Correction to: Scientific Reports https://doi.org/10.1038/s41598-018-27521-y, published online 15 June 2018
The Acknowledgements section in this Article is incomplete.
“The study was supported by the NVKP_16-1-2016-0037 and the FIEK_16-1-2016-0005 grants of the National Research, Development and Innovation Office, Hungary.”
should read:
“The study was supported by EFOP-3.6.3-VEKOP-16-2017-00009 grant and by the NVKP_16-1-2016-0037 and the FIEK_16-1-2016-0005 grants of the National Research, Development and Innovation Office, Hungary.”
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Nagy, Á., Lánczky, A., Menyhárt, O. et al. Author Correction: Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets. Sci Rep 8, 11515 (2018). https://doi.org/10.1038/s41598-018-29514-3
Published:
DOI: https://doi.org/10.1038/s41598-018-29514-3
This article is cited by
-
Distinct profiles of proliferating CD8+/TCF1+ T cells and CD163+/PD-L1+ macrophages predict risk of relapse differently among treatment-naïve breast cancer subtypes
Cancer Immunology, Immunotherapy (2024)
-
A Pilot Study Based on the Correlation Between Whole Exome and Transcriptome Reveals Potent Variants in the Indian Population of Cervical Cancer
Indian Journal of Microbiology (2024)
-
BARD1 mystery: tumor suppressors are cancer susceptibility genes
BMC Cancer (2022)
-
Up-regulation of MTHFD2 is associated with clinicopathological characteristics and poor survival in ovarian cancer, possibly by regulating MOB1A signaling
Journal of Ovarian Research (2022)
-
Epigenetically silenced apoptosis-associated tyrosine kinase (AATK) facilitates a decreased expression of Cyclin D1 and WEE1, phosphorylates TP53 and reduces cell proliferation in a kinase-dependent manner
Cancer Gene Therapy (2022)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.